Novel adjuvants in allergen-specific immunotherapy: where do we stand?

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 35,294 followers.

Novel adjuvants in allergen-specific immunotherapy: where do we stand? https://t.co/jVZUCeiSI3

RT @FrontImmunol: New Research: Novel adjuvants in allergen-specific immunotherapy: where do we stand?: Type I hypersensitivity, or so-call…

RT @FrontImmunol: New Research: Novel adjuvants in allergen-specific immunotherapy: where do we stand?: Type I hypersensitivity, or so-call…

RT @FrontImmunol: New Research: Novel adjuvants in allergen-specific immunotherapy: where do we stand?: Type I hypersensitivity, or so-call…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.